ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 130 filers reported holding ANAPTYSBIO INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,814,000 | +18.0% | 52,217 | +3.1% | 0.01% | 0.0% |
| Q4 2018 | $3,231,000 | -57.3% | 50,646 | -33.3% | 0.01% | 0.0% |
| Q3 2018 | $7,574,000 | +199.7% | 75,906 | +113.4% | 0.01% | +66.7% |
| Q2 2018 | $2,527,000 | -27.4% | 35,576 | +6.4% | 0.00% | -40.0% |
| Q1 2018 | $3,479,000 | +5.7% | 33,424 | +2.3% | 0.01% | +25.0% |
| Q4 2017 | $3,290,000 | +344.0% | 32,666 | +54.0% | 0.00% | +300.0% |
| Q3 2017 | $741,000 | +225.0% | 21,210 | +122.8% | 0.00% | – |
| Q2 2017 | $228,000 | +6.5% | 9,520 | +23.4% | 0.00% | – |
| Q1 2017 | $214,000 | – | 7,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |